Impact of permanent pacemaker on mortality after transcatheter aortic valve implantation: the PRAGMATIC (Pooled Rotterdam-Milan-Toulouse in Collaboration) Pacemaker substudy

EuroIntervention 2016;12:1185-1193. DOI: 10.4244/EIJV12I9A192

Gennaro Giustino
Gennaro Giustino1,2, MD; Robert M.A. Van der Boon3, MD, PhD; Javier Molina-Martin de Nicolas4, MD; Nicolas Dumonteil5, MD; Alaide Chieffo1, MD; Peter P.T. de Jaegere3, MD, PhD; Didier Tchetche4, MD; Bertrand Marcheix5, MD, PhD; Damien Millischer4, MD; Romain Cassagneau4, MD; Didier Carrié5, MD, PhD; Nicolas M. Van Mieghem3, MD, PhD; Antonio Colombo1*, MD
1. Department of Cardio-Thoracic and Vascular Diseases, San Raffaele Scientific Institute, Milan, Italy; 2. The Icahn School of Medicine at Mount Sinai Cardiovascular Institute, New York, NY, USA; 3. Department of Interventional Cardiology, Thoraxcenter, E

Aims: We sought to evaluate the impact of permanent pacemaker (PPM) implantation on two-year mortality and one-year left ventricular ejection fraction recovery (∆LVEFR=one-year LVEF–basel

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

left ventricular ejection fractionmortalitypacemakertavi
Interventions for valvular diseaseTAVITools, devices and techniques
Read next article
Large left lung mass: an unexpected finding

Latest news